These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35473535)

  • 1. Implications and Efficacy of Aromatase Inhibitors in Combination and Monotherapy for the Treatment of Lung Cancer.
    Rahal BA; Bardaweel SK
    Anticancer Agents Med Chem; 2022; 22(18):3114-3124. PubMed ID: 35473535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Estrogen Receptor Modulators (SERMs) Synergize with Cisplatin, Induce Apoptosis and Suppress Cellular Migration and Colony Formation of Lung Cancer Cells.
    Alsous L; Bardaweel S
    Anticancer Agents Med Chem; 2022; 22(9):1826-1836. PubMed ID: 35546505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models.
    Bardaweel SK; Dahabiyeh LA; Akileh BM; Shalabi DD; AlHiary AK; Pawling J; Dennis JW; Rahman AMA
    Anticancer Agents Med Chem; 2022; 22(8):1611-1621. PubMed ID: 34515014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of aromatase alters the mechanical and rheological properties of non-small-cell lung cancer cell lines affecting cell migration.
    Giannopoulou E; Siatis KE; Metsiou D; Kritikou I; Papachristou DJ; Kalofonou M; Koutras A; Athanassiou G; Kalofonos HP
    Biochim Biophys Acta; 2015 Feb; 1853(2):328-37. PubMed ID: 25450981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effect of exemestane in lung cancer cells.
    Koutras A; Giannopoulou E; Kritikou I; Antonacopoulou A; Evans TR; Papavassiliou AG; Kalofonos H
    Mol Cancer; 2009 Nov; 8():109. PubMed ID: 19930708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines.
    Abdul Satar N; Ismail MN; Yahaya BH
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
    Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
    J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells.
    Namwan N; Senawong G; Phaosiri C; Kumboonma P; Somsakeesit LO; Samankul A; Leerat C; Senawong T
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop.
    Zhang W; Shi H; Chen C; Ren K; Xu Y; Liu X; He L
    Phytomedicine; 2018 Sep; 48():51-61. PubMed ID: 30195880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms.
    Ye MX; Zhao YL; Li Y; Miao Q; Li ZK; Ren XL; Song LQ; Yin H; Zhang J
    Phytomedicine; 2012 Jun; 19(8-9):779-87. PubMed ID: 22483553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
    Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
    Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor.
    Tkalia IG; Vorobyova LI; Grabovoy AN; Svintsitsky VS; Tarasova TO; Lukyanova NY; Todor IN; Chekhun VF
    Exp Oncol; 2014 Sep; 36(3):184-90. PubMed ID: 25265352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
    Shen L; Li Z; Shen S; Niu X; Yu Y; Li Z; Liao M; Chen Z; Lu S
    Lung Cancer; 2012 Dec; 78(3):193-200. PubMed ID: 22985911
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Wang HL; Chang JC; Fang LW; Hsu HF; Lee LC; Yang JF; Liang MT; Hsiao PC; Wang CP; Wang SW; Chang CC; Houng JY
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30551590
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial.
    Bundred NJ; Cramer A; Morris J; Renshaw L; Cheung KL; Flint P; Johnson R; Young O; Landberg G; Grassby S; Turner L; Baildam A; Barr L; Dixon JM
    Clin Cancer Res; 2010 Mar; 16(5):1605-12. PubMed ID: 20179229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exemestane metabolites: Synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line.
    Varela CL; Amaral C; Tavares da Silva E; Lopes A; Correia-da-Silva G; Carvalho RA; Costa SC; Roleira FM; Teixeira N
    Eur J Med Chem; 2014 Nov; 87():336-45. PubMed ID: 25277066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of antitumor drugs, exemestane and erlotinib, induced resistance mechanism in H358 and A549 non-small cell lung cancer (NSCLC) cell lines.
    Kritikou I; Giannopoulou E; Koutras AK; Labropoulou VT; Kalofonos HP
    Pharm Biol; 2013 Nov; ():. PubMed ID: 24192333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel synthetic curcumin derivative MHMM-41 induces ROS-mediated apoptosis and migration blocking of human lung cancer cells A549.
    Zhou GZ; Li AF; Sun YH; Sun GC
    Biomed Pharmacother; 2018 Jul; 103():391-398. PubMed ID: 29674274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.
    Lisztwan J; Pornon A; Chen B; Chen S; Evans DB
    Breast Cancer Res; 2008; 10(4):R56. PubMed ID: 18611244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor.
    Wang X; Chen S
    Cancer Res; 2006 Nov; 66(21):10281-6. PubMed ID: 17079446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.